Small Cell Prostate Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-11-29
Clinical Trial Update: A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer [Phase 2]
Phase II trial of MLN8237 in metastatic castration-resistant and neuroendocrine prostate cancer completed; results posted in 2017.